Clinical Trials
Naveris, Inc. Initiates Phase II Clinical Trial for HPV-Driven Head and Neck Cancer at MSKCC
-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of a Phase II clinical study in minimal ...
April 25, 2024 | News
Hanmi Pharmaceutical Partners with MSD to Advance Immuno-Oncology Drug BH3120 in New Clinical Trial
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesit...
April 24, 2024 | News
Hyundai Bioscience Launches Clinical Trials for Innovative Niclosamide-Based Cancer Drug
Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative...
April 23, 2024 | News
Kintor Pharma Advances to Phase III with GT20029, Pioneering Topical Treatment for Male Androgenetic Alopecia
Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...
April 22, 2024 | News
GenFleet Therapeutics Secures FDA Approval for Pioneering Phase III KRAS G12C Inhibitor Trial in Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Adm...
April 22, 2024 | News
Hyundai Bioscience to Conduct Global Clinical Trials for Groundbreaking Dengue Treatment
Hyundai Bioscience CEO Oh Sang-gi, announced its plan to launch global clinical trials for a revolutionary treatment targeting all four serotypes of ...
April 22, 2024 | News
YS Biopharma's New HBV Vaccine Gains Clinical Trial Approval in the Philippines
YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therap...
April 19, 2024 | News
Cognivia Secures Strategic Investment to Revolutionize Clinical Trials with AI
Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly annou...
April 19, 2024 | News
Artiva Biotherapeutics Initiates First U.S. Trial of Allogeneic NK Cell Therapy for Lupus Nephritis
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-bas...
April 18, 2024 | News
Actinogen Medical Launches Phase 2b XanaMIA Trial for Alzheimer's, Marks First Patient Treatment
Actinogen Medical Limited (ASX: ACW) announces that the first patient has been randomized and treated in the XanaMIA phase 2b clin...
April 16, 2024 | News
Singapore-Based Respiree Expands to U.S., Establishes Presence at Johnson & Johnson Innovation Hub in South San Francisco
Respiree announced that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francis...
April 16, 2024 | News
Teva Validates AJOVY® Efficacy and Safety in China Phase 3 Migraine Trial
AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...
April 15, 2024 | News
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
These findings build upon the compelling clinical activity demonstrated by BOT/BAL across nine different cancer types in Agenus' broad clinical dev...
April 13, 2024 | News
Kexing Biopharm Advances Pediatric Care with Phase III Trial of Novel RSV Inhalation Therapy
Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned sub...
April 11, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
